RecruitingNCT07199803

OBS-QoR-10 in Patients With and Without Postpartum Hemorrhage

Comparing the Obstetric Quality of Recovery-10 (OBS-QoR-10) in Patients With and Without Postpartum Hemorrhage: A Matched Case-control Study


Sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Enrollment

152 participants

Start Date

Oct 3, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Postpartum hemorrhage (PPH) remains a leading cause of maternal death and morbidity. Moreover, it also contributes to psychological trauma such as depression and post-traumatic stress disorder. The American College of Obstetrics and Gynecology (ACOG) and the Society for Maternal Fetal Medicine (SMFM) defines this morbidity as an unintended outcome in the birthing process that may have significant short-term and long-term consequences to an individual's health. A recent study in 2018 developed core outcomes set for PPH through Delphi consensus encompassing elements of prevention and management of PPH. Patient-reported outcomes, breastfeeding, and overall sense of wellbeing were not included in the final outcome set. Nevertheless, investigators felt strongly that they should be included, but further work was needed to assess the factors influencing the quality of recovery in the context of PPH. This is aligned with increasing recognition that patient experiences are important to improving the quality of care and quality of recovery after Cesarean delivery. The most effective, i.e. validated tool for assessing postpartum recovery is the Obstetric Quality of Recovery-10 (Obs-QoR-10). However its application in patients with PPH remains unexplored. It would appear logical that patient experiencing PPH experience a potentially more challenging recovery process which may include more surgical complications, depressive symptoms, sleep deprivation, physical exhaustion and stress due to unexpected and undesired delivery events. This study aims to compare Obs-QoR-10 scores in patients with and without PPH to evaluate the impact of severe postpartum bleeding on recovery outcomes using a matched case-control design. The investigators plan to determine the differences in Obs-QoR-10 scores between patients who experience PPH during childbirth and those deliver without PPH, and to evaluate the impact of PPH on specific recovery domains (physical comfort, emotional well-being, and functional recovery).


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria10

  • Patients aged 18 years or older who have delivered at Mount Sinai Hospital.
  • Delivery via vaginal or cesarean delivery with neuraxial analgesia or anesthesia
  • Ability to communicate in English (to answer OBSQoR-10 survey) PPH Cohort
  • Quantitative Blood Loss (QBL) ≥ 1000 mL or,
  • Transfusion of blood due to PPH or,
  • Transfer to ICU level care due to PPH
  • Significant PPH intervention, i.e. hysterectomy or arterial embolization Non-PPH
  • QBL \< 500 mL and,
  • No transfusion of blood products, and
  • No need for elevated care environment, i.e. HAU or ICU

Exclusion Criteria6

  • Patients with pre-existing psychiatric disorders affecting recovery assessment.
  • Patients who experience severe obstetric complications other than PPH (e.g., eclampsia, uterine rupture).
  • Overdistended uterus due to; Polyhydramnios (amniotic fluid index \>24 cm) or multiple gestation
  • History of previous PPH (documented with blood loss of \>1000 ml, blood transfusion, use surgical methods such as Bakri balloon, B-Lynch sutures, uterine artery ligation or embolization)
  • BMI \> 50
  • Language barrier (English)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

The ObsQoR-10 tool aims to quantitatively measure functional recovery at 24 hours postpartum. It includes 10 questions on a 0 to 10 scale, aimed at pain management, the adverse effects of narcotics and the perception of recovery by the patient.


Locations(1)

Mount Sinai Hospital

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07199803


Related Trials